- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 279/12 - 1,4-ThiazinesHydrogenated 1,4-thiazines not condensed with other rings
Patent holdings for IPC class C07D 279/12
Total number of patents in this class: 167
10-year publication summary
|
13
|
9
|
8
|
14
|
17
|
7
|
11
|
13
|
11
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Global Blood Therapeutics, Inc. | 183 |
11 |
| Amgen Inc. | 4074 |
6 |
| Cassava Science, Inc. | 13 |
5 |
| Merck Sharp & Dohme LLC | 3748 |
5 |
| Imago Biosciences, Inc. | 38 |
4 |
| Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China | 185 |
4 |
| The University of Melbourne | 539 |
4 |
| The University of Toledo | 426 |
4 |
| Novartis AG | 10849 |
3 |
| Janssen Pharmaceutica N.V. | 3392 |
3 |
| Pharmaxis Ltd | 39 |
3 |
| Washington State University | 484 |
3 |
| Lockheed Martin Energy, LLC | 143 |
3 |
| Aligos Therapeutics, Inc. | 152 |
3 |
| Orsobio, Inc. | 13 |
3 |
| Merck Sharp & Dohme Corp. | 2194 |
2 |
| Boehringer Ingelheim International GmbH | 4650 |
2 |
| FUJIFILM Corporation | 29367 |
2 |
| Sumitomo Chemical Company, Limited | 9046 |
2 |
| Alexion Pharmaceuticals, Inc. | 635 |
2 |
| Other owners | 93 |